Compare OTTR & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OTTR | ITGR |
|---|---|---|
| Founded | 1907 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.3B |
| IPO Year | 2009 | 2000 |
| Metric | OTTR | ITGR |
|---|---|---|
| Price | $87.44 | $126.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $91.14 |
| AVG Volume (30 Days) | 159.8K | ★ 714.6K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.54 | 1.17 |
| Revenue | $1,299,640,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $1.99 | $1.69 |
| Revenue Next Year | $3.83 | $6.53 |
| P/E Ratio | ★ $57.50 | $108.03 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $74.15 | $62.00 |
| 52 Week High | $95.09 | $126.80 |
| Indicator | OTTR | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 76.12 |
| Support Level | $84.33 | $124.84 |
| Resistance Level | $90.44 | $126.80 |
| Average True Range (ATR) | 1.58 | 0.30 |
| MACD | -0.18 | -0.69 |
| Stochastic Oscillator | 13.18 | 71.20 |
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.